Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

15 results
Display

Normal range of serum ALT level in patients with chronic hepatitis

Seo YS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Angiomyolipoma

Lee WJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hepatic adenomatosis in glycogen storage disease

Kwon JE, Park YN

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease

Kim MY, Baik SK

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent developments in systemic chemotherapy for hepatocellular carcinoma

Han CJ

Despite recent developments in various chemotherapeutic agents and the performing of numerous clinical trials, chemotherapy still produces unsatisfactory results in hepatocellular carcinoma due to poor clinical benefit compared with untreated...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of ticlopidine induced acute cholestatic hepatitis and pure red cell aplasia

Lee JY, Park EB, Ahn JH, Suh SJ, Jung YK, Kim JH, Shin BK, Yang JH, Yeon JE, Byun KS

Ticlopidine inhibits platelet aggregation and provides beneficial secondary prevention of cerebrovascular and coronary artery disease. Frequently reported adverse effects of ticlopidine include diarrhea, nausea, and rash. However, to our knowledge,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Nonalcoholic steatohepatitis: Pathogenesis and treatment

Park SH

Nonalcoholic fatty liver disease (NAFLD) is characterized by a wide spectrum of liver damage spanning steatosis, nonalcoholic steatohepatitis (NASH), cryptogenic liver cirrhosis, and even to hepatocellular carcinoma. Investigations in the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hepatic myelopathy as a presenting neurological complication in patients with cirrhosis and spontaneous splenorenal shunt

Koo JE, Lim YS, Myung SJ, Suh KS, Kim KM, Lee HC, Chung YH, Lee YS, Suh DJ

Hepatic myelopathy is a rare complication of chronic liver disease that is associated with extensive portosystemic shunts. The main clinical feature of hepatic myelopathy is progressive spastic paraparesis in the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of allopurinol-induced granulomatous hepatitis with ductopenia and cholestasis

Yoon JY, Min SY, Park JY, Hong SG, Park SJ, Paik SY, Park YM

Allopurinol-induced hypersensitivity syndrome is characterized by an idiosyncratic reaction involving multiple-organs, which usually begins 2 to 6 weeks after starting allopurinol. In rare cases, the adverse reactions to allopurinol are...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Distribution of hepatitis C virus genotypes in Jeju Island

Lee H, Cho YK, Kim HU, Choi EK, Hyun S, Kang D, Jeong SU, Kim HJ, Kim KS, Song BC

BACKGROUNDS/AIMS: The hepatitis C virus (HCV) genotype affects clinical outcomes of HCV infection, in terms of the response to antiviral therapy and progression of chronic liver diseases, and shows...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of therapeutic results between combination therapy of peginterferon alpha-2a plus ribavirin and interferon alpha-2b plus ribavirin according to treatment duration in patients with chronic hepatitis C

Lee HJ, Eun JR, Choi JW, Kim KO, Moon HJ

BACKGROUND/AIMS: This study compared the efficacy and safety of combined peginterferon alfa (PEG-IFN) and ribavirin with that of combined interferon alpha (IFN-alpha) and ribavirin, according to the treatment duration...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C

Kim KT, Han SY, Kim JH, Yoon HA, Baek YH, Kim MJ, Lee SW, Jang JS, Lee JH, Roh MH

BACKGROUND/AIMS: The purpose of this study is to elucidate the efficacy and safety of combined peginterferon and ribavirin therapy in Korean patients with chronic HCV infection. METHODS: We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Factors affecting initial virologic response and emergence of resistant mutants after adefovir treatment in lamivudine-resistant chronic hepatitis B patients

Cho JH, Cheong JY, Kang JK, Park JS, Lee MH, Lim NK, Hong SP, Kim SO, Yoo WD, Cho SW

BACKGROUND/AIMS: Adefovir dipivoxil (adefovir) effectively inhibits both wild-type and lamivudine-resistant hepatitis B virus (HBV) replication. The development of adefovir resistance is both delayed and infrequent compared with lamivudine resistance....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis

Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH

BACKGROUND/AIMS: Alcohol and the hepatitis B virus (HBV) exert synergistic effects in hepatocelluar carcinogenesis. We aimed to elucidate the clinical significance of the antibody to hepatitis B core antigen...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease; Relation of non-alcoholic fatty liver disease to carotid atherosclerosis

Choi SY, Kim D, Kang JH, Park MJ, Kim YS, Lim SH, Kim CH, Lee HS

BACKGROUND/AIMS: Non-alcoholic fatty liver disease (NAFLD) is closely associated with abdominal obesity, dyslipidemia, hypertension, and Type 2 diabetes, which are all features of the metabolic syndrome. The aim of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr